Area of research
Pathology and Forensic Medicine · Cell Biology
Research interest
Research interests include Autoimmune Bullous Skin Diseases, Skin and Cellular Biology Research, Urticaria and Related Conditions, and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Enhancing randomized clinical trials with digital twins
Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council
S2k guidelines on diagnosis and treatment of linear <scp>IgA</scp> dermatosis initiated by the European Academy of Dermatology and Venereology
Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
Dupilumab-associated ocular manifestations: A review of clinical presentations and management
Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I
Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
Consensus statement for the treatment of infantile haemangiomas with propranolol
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines
Innate sensing of microbial products promotes wound-induced skin cancer
Suppression of TGF<sub>β</sub>and Angiogenesis by Type VII Collagen in Cutaneous SCC
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in <scp>A</scp>ustralia
Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting
Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris